Sonoma Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Accounts Receivable

12 Months Ended

Mar. 31, 2024

NOTE 4 – Accounts Receivable

Accounts receivable, net consists of the following:

Schedule of accounts receivable
	March 31,
	2024			2023
Accounts receivable	$	2,925,000		$	2,588,000
Less: discounts, rebates, distributor fees and returns		(27,000	)		(16,000	)
Total accounts receivable, net	$	2,898,000		$	2,572,000